Valuation: Bausch + Lomb Corporation

Market Cap 6.05B 5.38B 5.02B 4.57B 8.62B 582B 8.71B 60.72B 23.53B 297B 22.72B 22.22B 954B P/E 2026 *
-278x
P/E 2027 * 44x
Enterprise Value 10.5B 9.33B 8.7B 7.93B 14.96B 1,009B 15.1B 105B 40.82B 516B 39.41B 38.55B 1,655B EV / Sales 2026 *
1.91x
EV / Sales 2027 * 1.76x
Free-Float
12.7%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Bausch + Lomb Corporation

1 day+0.56%
1 week+1.07%
Current month+0.24%
1 month-5.33%
3 months-0.70%
6 months+3.34%
Current year-0.23%
1 week 16.6
Extreme 16.6
17.29
1 month 16.6
Extreme 16.6
18.27
Current year 14.65
Extreme 14.65
18.92
1 year 13.76
Extreme 13.765
18.92
3 years 10.45
Extreme 10.45
21.69
5 years 10.45
Extreme 10.45
21.95
10 years 10.45
Extreme 10.45
21.95
Manager TitleAgeSince
Chief Executive Officer 56 2023-03-05
Director of Finance/CFO 53 2021-12-31
Compliance Officer - 2023-07-31
Director TitleAgeSince
Director/Board Member 62 2021-12-31
Director/Board Member 69 2022-04-30
Director/Board Member 78 2022-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/12/26 Free

Director

11,776 0.0033%
8/12/26 Option

Director

11,776 0.0033%
8/12/26 Free

Director

11,776 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%+1.07%+15.45%+4.16% 6.05B
+0.41%-4.60%-27.34%+0.95% 167B
+0.85%-1.80%-8.83%+11.93% 111B
+1.05%+1.01%-24.91%+0.47% 105B
-1.24%-0.76%-49.04%-12.75% 74.82B
-0.69%+0.05%-0.48%+71.48% 59.11B
-0.86%+4.49%+17.49%+57.78% 51.8B
-1.02%-4.30%-8.18%-31.75% 48.5B
+0.52%+0.08%-18.01%+20.59% 40.79B
-1.00%-1.66%+28.21%-9.91% 32.54B
Average -0.14%-0.06%-7.57%+11.29% 69.62B
Weighted average by Cap. +0.07%-0.90%-15.90%+9.76%

Financials

2026 *2027 *
Net sales 5.49B 4.88B 4.56B 4.15B 7.83B 528B 7.91B 55.14B 21.37B 270B 20.63B 20.18B 867B 5.82B 5.17B 4.82B 4.4B 8.29B 559B 8.37B 58.37B 22.62B 286B 21.84B 21.36B 917B
Net income -60.83M -54.05M -50.44M -45.98M -86.71M -5.85B -87.52M -610M -237M -2.99B -228M -223M -9.59B 131M 117M 109M 99.22M 187M 12.62B 189M 1.32B 510M 6.45B 493M 482M 20.7B
Net Debt 4.45B 3.95B 3.69B 3.36B 6.34B 427B 6.4B 44.61B 17.29B 218B 16.69B 16.33B 701B 4.17B 3.7B 3.46B 3.15B 5.94B 401B 6B 41.83B 16.21B 205B 15.65B 15.31B 657B
Logo Bausch + Lomb Corporation
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
Employees
13,000
Date Price Change Volume
26-10-02 US$17.04 +0.59% 129,937
26-10-01 US$16.94 -0.35% 584,100
26-09-30 US$17.00 -0.82% 232,485
26-09-29 US$17.14 +1.12% 232,358
26-09-28 US$16.95 +0.53% 418,813
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
16.94USD
Average target price
19.04USD
Spread / Average Target
+12.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BLCO Stock